Logo

Astex Signs a Multi-Year Discovery Collaboration with Cardiff University Medicines Discovery Institute to Identify New Drugs for Neurodegenerative Diseases

Share this
Astex

Astex Signs a Multi-Year Discovery Collaboration with Cardiff University Medicines Discovery Institute to Identify New Drugs for Neurodegenerative Diseases

Shots:

  • Cardiff University will receive R&D funding and is eligible to receive development and regulatory fees if drug compounds progress along with royalty on the sales of any approved products
  • The collaboration will combine MDI’s drug discovery capabilities and the research expertise of Drs. Emyr Lloyd-Evans and Helen Waller-Evans in lysosomal biology with Astex’s fragment-based drug discovery platform to identify compounds that modulate lysosomal activity to develop new treatments for neurodegenerative diseases
  • Additionally, the partnership also supports and advances research to transform the lives of neurodegenerative diseases patients

Ref: Astex | Image: Astex

Related News:- Otsuka and Astex Report EMA's Acceptance of MAA for Fixed-Dose Combination of Decitabine and Cedazuridine to Treat Acute Myeloid Leukemia

Click here to­ read the full press release 

Senior Editor

Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions